Today, Investors.com officially released its "Investors.com 2026·54 Best Young Investors List". Mr. Pai Zhu, CEO of Efung Capital, stood out among numerous competitors and was named to the prestigious list, thanks to his profound industry insights and continuous deep cultivation in the biopharmaceutical field.

This list is initiated by Investors.com in collaboration with the Investors Research Institute. It aims to recognize a new generation of investors who possess a unique combination of technological acumen, industrial insight, and innovative action during this critical period of structural reshaping in the equity investment industry.

Entering 2026, the industry's logic is shifting from "scale expansion" to "quality enhancement," with VC/PE firms focusing more intensively on specialized and sophisticated sectors that drive niche innovation. Against this backdrop, young investors, through their rapid adoption of new technologies, adept use of AI tools, and spirit of challenging conventional wisdom, are becoming the core force in establishing a "new order" within the industry. This youthful energy is now guiding Efung Capital towards a new chapter of growth.

Looking ahead, Efung Capital will continue to focus on hard technology sectors such as biopharmaceuticals, high-end medical devices, and life sciences frontiers. Within a market environment characterized by the deepening of the registration-based IPO system and increasingly active M&A activities, we will further empower our portfolio companies, propel more of China's original innovations from the lab to the clinic and the market, deliver more stable returns for our investors, and contribute Efung's strength to the high-quality development of China's innovative pharmaceutical industry.

Salute to all the young people who are quietly dedicated to technological innovation!